Research and Development Agreements - Schedule of Research and Development Revenue from Related Party Relates to Revenue from Research and Development Agreements (Detail) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2020 |
Jun. 30, 2019 |
Jun. 30, 2020 |
Jun. 30, 2019 |
|
Revenue Recognition [Line Items] | ||||
Total research and development revenue | $ 6,040 | $ 5,211 | $ 7,840 | $ 11,624 |
Millennium Pharmaceuticals Inc | ||||
Revenue Recognition [Line Items] | ||||
Total research and development revenue | 3,063 | 5,211 | 3,396 | 11,624 |
Millennium Pharmaceuticals Inc | Takeda Individual Project Agreement | ||||
Revenue Recognition [Line Items] | ||||
Total research and development revenue | 0 | 0 | 0 | 54 |
Millennium Pharmaceuticals Inc | Takeda Development Agreement | ||||
Revenue Recognition [Line Items] | ||||
Total research and development revenue | 3,028 | 5,012 | 3,176 | 11,126 |
Millennium Pharmaceuticals Inc | Takeda Multi Target Agreement | ||||
Revenue Recognition [Line Items] | ||||
Total research and development revenue | $ 35 | $ 199 | $ 220 | $ 444 |
X | ||||||||||
- Definition Research and development revenues from collaboration agreements. No definition available.
|
X | ||||||||||
- Definition Revenue recognition. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|